Saturday, October 31, 2026

Samsung Galaxy Crew 2026: How 70 Creators Will Transform Your Experience with Galaxy Products

Samsung launches Galaxy Crew 2026, a program for 70 creators across diverse fields to engage Gen Z through content showcasing Galaxy products.

Chinese Electric Cars Make Big Gains on U.S. Stock Market

Chinese electric car stocks surged on the NYSE, with Nio rising 11.65%, following major economic stimulus measures from China.

2025 South Korea Education Spending: Monthly Average Drops to 458,000 KRW – What Does This Mean for Students?

Private education spending and participation decline, while household consumption and employment rates rise, indicating economic shifts in Korea.

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.

Seers to Highlight Earnings Growth, Global Business at Singapore NDR

Seers will use its first Singapore NDR since listing to showcase earnings growth and accelerate global expansion of its AI-powered medical monitoring and diagnostics business.

3billion Accelerates Global Expansion of AI Genetic Variant Interpretation Platform ZEBRA

3billion is accelerating the global expansion of its ZEBRA AI genetic variant interpretation platform by improving reliability, accessibility and clinical adoption across domestic and international medical and research institutions.

What Led to the Supreme Court’s Decision on Medical Liability in a Child’s Severe Drug Reaction?

A Supreme Court ruling states that doctors cannot be held criminally liable for not diagnosing drug allergy syndrome early in patients with liver failure.

GC BioPharma Pioneers AI-Based mRNA-LNP Vaccine Manufacturing: Smart Quality Management System to Launch in 2026

GC Biopharma has been selected as the lead research institution for a project on AI-based vaccine manufacturing and quality control.

K-Pharmaceuticals: How to Boost Exports with High-Value Products in 2026

To expand pharmaceutical exports, we must strengthen existing bases while pursuing product differentiation and entry into high-income countries.

Unlocking UAE: How Korean Biotech Firms Can Navigate Regulatory Hurdles in 2026

The Ministry of Food and Drug Safety will facilitate communication between local regulatory authorities and Korean bio companies for UAE market entry.

Expanded 119 Emergency Call Service: How It Protects Vulnerable Residents in 2026

The 119 Safe Call service expands to include residents in flood-risk areas and children who struggle to evacuate during fires.

Unlocking the Future: South Korea’s 2031 BCI Research Plan with 300 Primates

The government plans to secure 300 primates for brain-computer interface research by 2031, focusing on safety and performance validation.

SK Biopharm’s Bold Move: How MD Expertise is Shaping Global Drug Development in 2026

SK Biopharm is enhancing its global competitiveness in drug development by establishing a specialized R&D system for new drug candidates.

Lunit to Present 3 Lung Cancer AI Studies at WCLC, Highlighting Potential for Precision Treatment

Lunit will present three studies using its AI biomarker platform Lunit SCOPE IO at WCLC 2026, focusing on links between genetic mutations, the tumor microenvironment and treatment response.

Humedics Targets Southeast Asian Aesthetic Market With Participation in Thai Medical Aesthetics Conference

Humedics showcased its hyaluronic acid filler Elravie Premier at ASLS Bangkok 2026 and highlighted clinical experience and treatment techniques to expand its presence in Thailand and Southeast Asia.

Dong-A ST’s ‘HiCardi’ Expands to 6 Asia-Pacific Countries as Overseas Push Accelerates

Dong-A ST will supply its wearable patient monitoring platform HiCardi to six Asia-Pacific countries through Schiller Asia Pacific.

“A New Era for Skin Treatments Has Arrived”: Wontech Unveils ‘Oligio XM’ for First Time

Wontech unveiled its new flagship Oligio XM, combining radiofrequency and high-intensity focused ultrasound technologies in a single device.

Cholera Vaccine Use Expands From Emergency Response to Prevention, Spotlighting EuBiologics’ Supply Role

As cholera vaccination expands from emergency campaigns in outbreak areas to preventive immunization, EuBiologics is playing a growing role in global oral cholera vaccine supply.

Top News

- Our Sponsors Ad -

Follow us